Waverly Advisors LLC Makes New Investment in Haleon plc (NYSE:HLN)

Waverly Advisors LLC acquired a new stake in Haleon plc (NYSE:HLN - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm acquired 31,281 shares of the company's stock, valued at approximately $298,000.

Other hedge funds also recently added to or reduced their stakes in the company. Merit Financial Group LLC acquired a new stake in Haleon in the fourth quarter worth about $152,000. Atomi Financial Group Inc. raised its position in Haleon by 50.4% during the fourth quarter. Atomi Financial Group Inc. now owns 33,875 shares of the company's stock valued at $323,000 after acquiring an additional 11,357 shares in the last quarter. Janney Montgomery Scott LLC raised its stake in shares of Haleon by 13.3% in the 4th quarter. Janney Montgomery Scott LLC now owns 850,563 shares of the company's stock valued at $8,114,000 after acquiring an additional 99,666 shares in the last quarter. Brighton Jones LLC acquired a new position in shares of Haleon during the 4th quarter worth about $187,000. Finally, Geneos Wealth Management Inc. bought a new position in shares of Haleon during the 4th quarter worth about $35,000. 6.67% of the stock is owned by institutional investors and hedge funds.

Haleon Price Performance

Shares of Haleon stock traded up $0.10 during trading hours on Tuesday, reaching $11.24. The stock had a trading volume of 15,185,663 shares, compared to its average volume of 8,272,818. The firm has a market capitalization of $50.66 billion, a PE ratio of 33.06, a PEG ratio of 2.82 and a beta of 0.24. Haleon plc has a twelve month low of $8.25 and a twelve month high of $11.35. The company has a current ratio of 0.84, a quick ratio of 0.58 and a debt-to-equity ratio of 0.44. The stock's 50 day moving average is $10.33 and its 200 day moving average is $9.93.

Haleon (NYSE:HLN - Get Free Report) last announced its quarterly earnings results on Thursday, February 27th. The company reported $0.05 earnings per share (EPS) for the quarter. Haleon had a net margin of 10.85% and a return on equity of 14.76%. The business had revenue of $3.54 billion during the quarter, compared to the consensus estimate of $3.38 billion. Equities analysts expect that Haleon plc will post 0.43 earnings per share for the current fiscal year.

Haleon Increases Dividend

The business also recently disclosed a -- dividend, which will be paid on Thursday, June 5th. Stockholders of record on Friday, April 25th will be given a $0.1166 dividend. This is an increase from Haleon's previous -- dividend of $0.05. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, April 25th. Haleon's dividend payout ratio is currently 58.97%.

Wall Street Analyst Weigh In

HLN has been the topic of several research analyst reports. Hsbc Global Res cut shares of Haleon from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, March 5th. Deutsche Bank Aktiengesellschaft reissued a "hold" rating on shares of Haleon in a report on Monday, March 3rd. Wall Street Zen lowered Haleon from a "buy" rating to a "hold" rating in a research note on Thursday, May 22nd. HSBC reiterated a "hold" rating on shares of Haleon in a report on Wednesday, March 5th. Finally, Morgan Stanley raised shares of Haleon from an "equal weight" rating to an "overweight" rating and set a $11.25 price target on the stock in a research report on Friday, May 9th. Six investment analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the company's stock. Based on data from MarketBeat, Haleon presently has an average rating of "Moderate Buy" and a consensus price target of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.